Bausch Health
BHC
211 hedge funds and large institutions have $2.09B invested in Bausch Health in 2024 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 70 reducing their positions, and 49 closing their positions.
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
6% more capital invested
Capital invested by funds: $1.96B → $2.09B (+$125M)
7.06% less ownership
Funds ownership: 76.65% → 69.59% (-7.1%)
10% less funds holding
Funds holding: 234 → 211 (-23)
34% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 70
47% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 49
71% less call options, than puts
Call options by funds: $41.8M | Put options by funds: $146M
Top Buyers
| 1 |
GAM
Goldentree Asset Management
New York
|
+$45.9M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$43.5M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$17.7M |
| 4 |
MRCP
Maple Rock Capital Partners
Toronto,
Ontario, Canada
|
+$13.6M |
| 5 |
EP
Eversept Partners
New York
|
+$10.1M |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$80.2M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$52.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$40.5M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$22.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$20.1M |
BHC Hedge Fund Activity: Q3 2024 in Review
211 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2024, worth a combined $2.09B — up 6.4% from $1.96B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of BHC and 26 opened new positions — a net loss of 23 holders — while 70 trimmed existing stakes and 46 added.
The largest buyer was Goldentree Asset Management, adding an estimated $45.9M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $80.2M sold.
- 211 institutional investors held Bausch Health (BHC) as of Q3 2024, down from 234 in Q2 2024.
- Funds reported $2.09B of Bausch Health stock for Q3 2024, up 6.4% quarter-over-quarter.
- 26 funds opened new Bausch Health positions in Q3 2024 and 49 closed out, a net change of -23 holders.
- The largest Bausch Health buyer in Q3 2024 was Goldentree Asset Management, an estimated $45.9M added.
- The largest Bausch Health seller in Q3 2024 was Hudson Bay Capital Management, an estimated $80.2M sold.
Based on aggregated 13F filings for Q3 2024.